Matches in SemOpenAlex for { <https://semopenalex.org/work/W2072900640> ?p ?o ?g. }
Showing items 1 to 91 of
91
with 100 items per page.
- W2072900640 abstract "BACKGROUND AND PURPOSE: Patients with actively replicating human immunodeficiency virus (HIV) are highly radiosensitive and exhibit adverse reactions even at low irradiation doses. One of the major underlying causes are high intra- and extracellular levels of a virus-encoded peptide termed viral protein R (Vpr). As Vpr efficiently crosses the blood-brain barrier and accumulates in astrocytes, we examined whether its active subunit (Vpr52-96) may be utilized as drug in the treatment of glioblastoma multiforme. MATERIAL AND METHODS: Four glioblastoma-derived cell lines with and without lentivirus-mediated MGMT-overexpression (U251, U87MG, U251-MGMT, U87-MGMT) were exposed to Vpr52-96, 100 µM of temozolomide (TMZ), conventional photon irradiation (2-6 Gy) or to combinations of the three. Acute toxicities and LD50 were examined using the MTT proliferation assay. Apoptosis was detected using a luminescent reaction measuring caspase-3 and -7 activities (Caspase Glo®). Clonogenic survival (survival fraction, SF) was determined using the colony-forming assay. RESULTS: Treatment of U251 cells with 1, 10 and 20 µM of medium-dissolved Vpr52-96 yielded cell viability rates of 82.4 ± 3.2%, 32.6 ± 9.1% and 10.5 ± 4.8% respectively, corresponding to a LD50 of 4.0 ± 1.1 µM. For U87MG, the corresponding viability rates were 89.3 ± 4.4%, 61.2 ± 12.4% and 43.6 ± 17.8%, resulting in an LD50 of 15.7 ± 7.5 µM. Combined treatment (Vpr + RT and/or TMZ) showed additive, but not synergistic effects in MTT assays. Vpr induced apoptosis in all cell lines within 6-12 hours in a dose-dependent fashion. Clonogenic assays also revealed an additive effect but no sensitization towards irradiation. Vpr alone efficiently inhibited clonogenic survival (SF at 10 µM Vpr: 0.24 ± 0.06 for U251 and 0.35 ± 0.09 for U87MG). In contrast to TMZ, it acts independently from the MGMT expression status (SF of U251-MGMT at 10 µM Vpr: 0.2 vs. 0.9 at 100 µM TMZ; SF of U87-MGMT at 10 µM Vpr: 0.3 vs. 0.7 at 100 µM TMZ). SUMMARY: Vpr52-96 exhibits all traits of a chemotherapeutic drug that may be employed for the treatment of glioblastoma multiforme. The protein acts additively to current standard therapies and shows undiminished antiproliferative activity in MGMT-overexpressing cells." @default.
- W2072900640 created "2016-06-24" @default.
- W2072900640 creator A5005095447 @default.
- W2072900640 creator A5010375570 @default.
- W2072900640 creator A5020564767 @default.
- W2072900640 creator A5030024392 @default.
- W2072900640 creator A5031894590 @default.
- W2072900640 creator A5036762150 @default.
- W2072900640 creator A5043076568 @default.
- W2072900640 creator A5050123685 @default.
- W2072900640 creator A5051719057 @default.
- W2072900640 creator A5089884023 @default.
- W2072900640 date "2014-09-01" @default.
- W2072900640 modified "2023-09-27" @default.
- W2072900640 title "P03.05 * THE HIV-DERIVED PROTEIN VPR(52-96) HAS PRO-APOPTOTIC AND ANTIPROLIFERATIVE ACTIVITY IN GLIOBLASTOMA CELL LINES IN VITRO" @default.
- W2072900640 doi "https://doi.org/10.1093/neuonc/nou174.128" @default.
- W2072900640 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4185470" @default.
- W2072900640 hasPublicationYear "2014" @default.
- W2072900640 type Work @default.
- W2072900640 sameAs 2072900640 @default.
- W2072900640 citedByCount "0" @default.
- W2072900640 crossrefType "journal-article" @default.
- W2072900640 hasAuthorship W2072900640A5005095447 @default.
- W2072900640 hasAuthorship W2072900640A5010375570 @default.
- W2072900640 hasAuthorship W2072900640A5020564767 @default.
- W2072900640 hasAuthorship W2072900640A5030024392 @default.
- W2072900640 hasAuthorship W2072900640A5031894590 @default.
- W2072900640 hasAuthorship W2072900640A5036762150 @default.
- W2072900640 hasAuthorship W2072900640A5043076568 @default.
- W2072900640 hasAuthorship W2072900640A5050123685 @default.
- W2072900640 hasAuthorship W2072900640A5051719057 @default.
- W2072900640 hasAuthorship W2072900640A5089884023 @default.
- W2072900640 hasBestOaLocation W20729006401 @default.
- W2072900640 hasConcept C117262875 @default.
- W2072900640 hasConcept C153911025 @default.
- W2072900640 hasConcept C185592680 @default.
- W2072900640 hasConcept C190283241 @default.
- W2072900640 hasConcept C202751555 @default.
- W2072900640 hasConcept C2776194525 @default.
- W2072900640 hasConcept C2777389519 @default.
- W2072900640 hasConcept C2780783641 @default.
- W2072900640 hasConcept C502942594 @default.
- W2072900640 hasConcept C53227056 @default.
- W2072900640 hasConcept C54355233 @default.
- W2072900640 hasConcept C55493867 @default.
- W2072900640 hasConcept C62112901 @default.
- W2072900640 hasConcept C81885089 @default.
- W2072900640 hasConcept C86803240 @default.
- W2072900640 hasConceptScore W2072900640C117262875 @default.
- W2072900640 hasConceptScore W2072900640C153911025 @default.
- W2072900640 hasConceptScore W2072900640C185592680 @default.
- W2072900640 hasConceptScore W2072900640C190283241 @default.
- W2072900640 hasConceptScore W2072900640C202751555 @default.
- W2072900640 hasConceptScore W2072900640C2776194525 @default.
- W2072900640 hasConceptScore W2072900640C2777389519 @default.
- W2072900640 hasConceptScore W2072900640C2780783641 @default.
- W2072900640 hasConceptScore W2072900640C502942594 @default.
- W2072900640 hasConceptScore W2072900640C53227056 @default.
- W2072900640 hasConceptScore W2072900640C54355233 @default.
- W2072900640 hasConceptScore W2072900640C55493867 @default.
- W2072900640 hasConceptScore W2072900640C62112901 @default.
- W2072900640 hasConceptScore W2072900640C81885089 @default.
- W2072900640 hasConceptScore W2072900640C86803240 @default.
- W2072900640 hasLocation W20729006401 @default.
- W2072900640 hasLocation W20729006402 @default.
- W2072900640 hasOpenAccess W2072900640 @default.
- W2072900640 hasPrimaryLocation W20729006401 @default.
- W2072900640 hasRelatedWork W1426921023 @default.
- W2072900640 hasRelatedWork W1966565397 @default.
- W2072900640 hasRelatedWork W2019393954 @default.
- W2072900640 hasRelatedWork W2058850076 @default.
- W2072900640 hasRelatedWork W2066378353 @default.
- W2072900640 hasRelatedWork W2100457669 @default.
- W2072900640 hasRelatedWork W2130942146 @default.
- W2072900640 hasRelatedWork W2322016884 @default.
- W2072900640 hasRelatedWork W2355938294 @default.
- W2072900640 hasRelatedWork W2363125611 @default.
- W2072900640 hasRelatedWork W2365994572 @default.
- W2072900640 hasRelatedWork W2367064461 @default.
- W2072900640 hasRelatedWork W2369027780 @default.
- W2072900640 hasRelatedWork W2387242230 @default.
- W2072900640 hasRelatedWork W2394087929 @default.
- W2072900640 hasRelatedWork W2512622872 @default.
- W2072900640 hasRelatedWork W2794400679 @default.
- W2072900640 hasRelatedWork W3037124968 @default.
- W2072900640 hasRelatedWork W3181641533 @default.
- W2072900640 hasRelatedWork W75820282 @default.
- W2072900640 isParatext "false" @default.
- W2072900640 isRetracted "false" @default.
- W2072900640 magId "2072900640" @default.
- W2072900640 workType "article" @default.